Abstract
Introduction
With advancements in imaging technology, researchers have been able to identify more distinctive imaging features of central serous chorioretinopathy (CSC). However, existing research primarily concentrates on young patients aged 50 years and below, leaving a dearth of studies on elderly CSC patients. Previous studies indicate that elderly CSC patients may exhibit unique imaging characteristics and have a clinical prognosis that significantly differs from younger patients. This study aimed to evaluate the characteristics of retina, choroid structure, and blood flow in elderly patients with chronic CSC (cCSC) examined multimode imaging and try to find new pathogenesis information of it.
Methods
Using a cut-off age of 50 years, patients with chronic central serous chorioretinopathy were divided into two groups: older and younger. The control group consisted of 40 healthy individuals, with their right eyes assigned. Various clinical features were recorded, including the incidence of ellipsoid zone rupture (EZ-), fibrin in the subretinal fluid (SRF), pachydrusen, subretinal drusenoid deposits (SDD), pigment epithelial detachment (PED), double-layer sign (DLS), and choroidal lipid globule cavern. Measurements were taken for the thickness of the outer nuclear layer (ONL), the length of the extended outer photoreceptor segment (POS), the height and width of SRF, the vascular density of each layer of the retinal capillary plexus, the central macular thickness (CMT), and the subfoveal choroidal thickness (SFCT).
Results
The proportion of females in the elderly group (43.75%) was significantly higher than that in the youth group (22.41%) (p = 0.034). The degree of hyperopia in the elderly group (1.03 ± 0.73) was higher than that in the youth group (0.26 ± 1.06), with a significant difference in BCVA (p = 0.05). The thickness of SFCT, CMT, ONL in the elderly group, and the length of photoreceptor outer segment in the elderly group were thinner than those in the youth group (p < 0.05). Choroidal capillary perfusion area (CCPA), macular area, and paramacular area were lower in the elderly group than those in the youth group in the full scan range (p < 0.05). The blood flow densities of deep capillary plexus (DCP), intermediate capillary plexus (ICP), and superficial capillary plexus (SCP) in the whole scan range, macular area, and paramacular area were lower in the elderly group than in the youth group, but the differences were not statistically significant.
Conclusions
In conclusion, our data suggest that elderly patients with cCSC may experience different disease outcomes. Elderly cCSC patients exhibit less gender bias, poorer vision, more severe structural damage and ischemia in the choroid and retina, and have a higher risk of develo** choroidal neovascularization.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Why carry out this study? |
Limited research has been conducted on geriatric chronic central serous chorioretinopathy, resulting in a lack of understanding regarding its clinical characteristics and disease progression. |
This study aims to explore the potential differences in imaging features and prognosis between older and younger patients with chronic chorioretinopathy (cCSC). |
What was learned from the study? |
Elderly patients with central chronic serous chorioretinopathy may experience different disease outcomes. |
Elderly cCSC patients exhibit less gender bias, poorer vision, more severe structural damage and ischemia in the choroid and retina and have a higher risk of develo** choroidal neovascularization. |
Introduction
Central serous chorioretinopathy (CSC) is a disease characterized by the detachment of the retina, with or without detachment of the retinal pigment epithelium (PED). This condition is associated with increased permeability in the choroid and dysfunction of the retinal pigment epithelium [1, 2]. CSC typically presents with varying degrees of visual loss or blurred vision, distortion, diminution of vision, and changes in color vision [3]. The diagnosis of CSC usually involves the use of fluorescein angiography (FFA) and indocyanine green angiography (ICGA), which are considered the gold standard. FFA reveals one or more leakage points at the level of the retinal pigment epithelium, while ICGA shows increased volume, permeability, and delayed filling of choroidal capillaries in multiple regions [4,5,6]. However, the invasive nature of FFA and ICGA limits their widespread use. Non-invasive imaging techniques such as SD-OCT and subsequent SS-OCT have made it possible to observe the retina, choroid, and even the sclera [7]. Previous studies have demonstrated that CSC patients exhibit significantly increased choroidal thickness, expanded large and middle choroidal vessels, attenuated choroidal capillaries, and abnormal retinal perfusion compared to normal controls [8,9,10].
CSC affects predominantly middle-aged people (30 to 50 years old) with a mean age of onset around 40 years old (39 to 41 years) and has a significant male preference [11,12,13]. The incidence rate of senile CSC is low, and it is easy to be complicated with choroidal neovascularization. Its clinical manifestations are very different from those of young CSC patients, and it is easy to confuse age-related macular degeneration (AMD) and polypoid choroidal vasculopathy (PCV), which makes the diagnosis of elderly CSC patients difficult [14, 15]. The number of elderly CSC patients seems to be increasing due to the aging population and the development of multimodal imaging. However, we know little about the unique pathological changes and clinical manifestations of elderly CSC patients.
Our purpose is to investigate the characteristic changes of retina, choroid structure, and blood flow in elderly patients with cCSC using scanning laser fundus color photography, FFA, ICGA, SS-OCT, SS-OCTA, and other imaging technologies, explore the unique clinical characteristics them and reveal new information about its pathogenesis.
Methods
This retrospective study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University, and all research and data collection complied with the Declaration of Helsinki. Patients were informed of the risks of invasive examinations and signed informed consent forms.
Newly diagnosed treatment-naïve chronic CSC patients were included in this study from June 2021 to January 2023 at the First Affiliated Hospital of Zhengzhou University. They were divided into two groups according to age: the young group (aged between 20 and 50 years old), 45 men with 47 eyes and 13 women with 15 eyes; the elderly group (age ≥ 50 years old), 18 males with 20 eyes and 14 females with 17 eyes. Among the young group, no complications were observed. However, in the elderly group, seven patients had comorbidities of hypertension, three patients had comorbidities of diabetes, and two patients had comorbidities of lower limb varicose veins. At the same time, we recruited 40 age- and sex-matched normal controls (40 eyes), all of whom were included in the right eye data for statistical analysis.
Chronic central serous chorioretinopathy was diagnosed as a neurosensory detachment resulting from one or more sites of leakage at the level of the retinal pigment epithelium (RPE) during the initial clinical examination. Additionally, there was evidence of persistent subretinal fluid (SRF) lasting for a duration of 3 months or longer. PCV can be ruled out by the presence of polypoidal lesions on SS-OCT B-scan images or ICGA. AMD can be ruled out by evaluating choroidal thickness and leakage pattern on FFA. Exclusion criteria include: (1) other retinal or choroidal diseases those can cause SRF; (2) the patient has a history of laser photocoagulation or other eye surgery; (3) choroidal neovascularization (CNV) was detected by OCT angiography (OCTA) or FFA; (4) poor image quality cannot be accurately analyzed; (5) high myopia, equivalent spherical lens > — 6D or eye axis > 26 mm.
All CSC patients received complete ophthalmic examination, including optometry, intraocular pressure measurement, slit lamp biomicroscope, scanning laser fundus color photography, FFA, SS-OCT, SS-OCTA (SS-OCTA, VG200D, micro-image, Luoyang, China), and some patients received ICGA examination. The OCT instrument VG-200 used in this study is equipped with a scanning laser with a central wavelength of 1050 nm, with a scanning speed of 200000A-Scans/s, axial resolution of 1.8 µm, and scanning depth of 6 mm. All the eyes examined were centered on the fovea of the macula, and the images were obtained by using Angio 6 mm × 6 mm 512 × 512 R4 and Star 18Line R16 scanning modes. The choroid is defined as the area from the base boundary of RPE-Bruch membrane complex to the junction of choroid and sclera. Except FFA and ICGA, healthy subjects received the same ophthalmic examination as CSC patients.
In this study, we recorded the demographic and basic clinical characteristics of cCSC patients at the time of treatment, such as age, sex, eye type, equivalent spherical lens degree, BCVA (expressed in logarithm of the equivalent value of the minimum resolution angle (logMAR). According to SS-OCT b-scan images, determine whether there are ruptured ellipsoid zone (EZ-), subfoveal fibrin in SRF, pachydrusen, subretinal drusenoid deposits (SDD), pigment epithelial detachment (PED, defined as dome-shaped detachment of the pigment epithelium from Bruchx’s membrane), double layer sign (DLS, defined as the detachment of RPE from the shallow irregular elevation of irregularly pigmented epithelium on Bruch's membrane), choroidal lipid globule cavern (choroidal lipid globule cavern is defined as the appearance of choroidal void, focal ellipsoid low reflection area in the Sattler and Haller layers, with a high penetration imaging trail behind, and no blood flow signal in OCTA [22, 30, 31]. Some studies have shown that the presence of fibrin in subretinal fluid is related to the serious damage of RPE and poor visual acuity [32]. The incidence of fibrin in our cohort is significantly higher in the elderly group.
Drusen are deposits of yellow-white extracellular debris composed of complement protein, esterified and non-esterified cholesterol, apolipoprotein, carbohydrate and trace elements, which are located above the retinal pigment epithelium (RPE) or between RPE and Bruch membrane. Soft glass verruca and reticular pseudovitreous verruca (also known as verruciform sediment SDD) are considered as typical pathological changes of age-related age degeneration (AMD) [33, 34]. Rick Spaide reported in 2018 that pachydrusen, a special entity, was isolated, with a diameter greater than 125 μm. It is related to choroidal thickening in non-exudative macular degeneration [35]. Hidetaka et al. [36] studied 302 eyes with CSC and found that the incidence of pachydrusen in CSC was 27.2%, and often located in the delayed area of choroidal capillary filling and above the dilated choroidal vessels. Kihwang et al. [37] concluded that the attenuation of choroidal capillaries was the main reason for the occurrence of pachydrusen and found that the incidence of pachydrusen in cCSC was closely related to age. In this study, we found that the probability of pachydrusen and SDD was significantly higher in the elderly group than in the younger group, but no soft drusen was found in either group. Also, the choroidal capillary perfusion area was markedly lower in the elderly group than that in the young group, supporting the above view. Jay et al. [38] believed that pachydrusen might be a potential risk factor for the development of PCD. When the eyes with pachydrusen developed macular neovascularization (MNV), the main manifestation was PCV [39]. The incidence of SDD in our cohort is very low and only found in the elderly group. It is reported that the incidence of SDD in PCV is 4.1%, which is considered as an independent risk factor for neovascularization [40], while the incidence of pachydrusen in PCV is 70% [41]. We believe that elderly cCSC patients with hyaline warts are more likely to develop PCV. In the next study, we will perform a longitudinal observation of elderly cCSC patients with hyaline to validate our view.
Friedman and Smith [42] first described the existence of choroidal lipid globule cavern in human eyes after death. Rosa et al. [43] used OCT to observe the focal ellipsoid low reflection area at the choroidal level in patients with AMD map-like atrophy, followed by a high penetration imaging trail. There was no blood flow signal in OCTA, and it was proved from the histology that the low reflection area was lipid droplets. Subsequently, some studies showed that in about 52% of eyes with thick choroidal membranes there are lipid granular cavities. Compared with the normal control and AMD patients, cCSC patients had a greater size and number of lipid grain-like cavities patients, and more cavities appeared in the area of increased choroidal vascular permeability, which was associated with increased choroidal thickness and the loss of choroidal stroma [17]. The incidence of choroidal lipid globule cavern in both groups was 56.76 and 50.82%, respectively, suggesting that choroidal matrix loss and lipidation in cCSC patients also explain, to some extent the decrease in choroidal thickness in the elderly group. The increase in lipid-like cavities means the increase in extracellular lipid deposition, which is involved in the process of choroidal oxidative stress. However, histology shows no evidence of inflammatory cells in the vicinity of the lipid droplets [43]. The prognostic significance of lipid-like cavities on cCSC still needs further study.
The nutrients of outer layer of retina (outer nuclear layer, photoreceptor layers and retinal pigment epithelial layer) is mainly supplied by choroidal capillary [44], and nutrients of the middle layer of retina (inner core layer and inner subordinate layer) and inner layer (nerve fiber layer and ganglion cell layer) are supplied by retinal capillary [45]. Vascular dilation and attenuation of choroidal capillaries in CSC patients have been widely recognized. However, there are few studies on their retinal capillary system, and little is known about the blood supply of the inner and middle retina of CSC among the elderly and young groups. Compared with the control group, CCPA, DCP, ICP and SCP were significantly reduced in the cCSC group. It proved that cCSC affects not only affected the choroidal vascular system, but also affected the retinal capillary system, and the whole retina was in a state of hypoperfusion. The CCPA reduction in the elderly group is particularly significant compared with the young group, suggesting that the blood supply of the outer retina in the elderly group is seriously insufficient, which corresponds to the more serious destruction of RPE [44]. At the same time, the hypoperfusion of choroidal capillaries is a trigger for increased VEGF secretion, and the risk of neovascularization is significantly increased in the elderly group. [46]The retinal capillary system provides a powerful supply for the inner and middle retinal membranes with active metabolism [45]. The decrease in blood perfusion of DCP, ICP and SCP will definitely lead to the disorder of metabolism in the corresponding retinal regions. Although there were no statistical difference in DCP, ICP, and SCP perfusion between the elderly group and the young group, the elderly group was lower in all measured ranges, which corresponded to the shorter ONL thickness and POS length in the elderly group. At present, little is known about the role of decreased retinal capillary perfusion in the pathogenesis of CSC. We believe that it may be caused by the compression of the retina by SRF. However, some patients with little SRF may also have serious severe middle and inner retinal perfusion deficits, which depends on further research.
There are limitations in this study: (1) The subjects included in the study are all Han Chinese, and the results may not be applicable to cCSC patients of other races; (2) It is a challenge to accurately identify the integrity of EZ when there are many SRFs, especially in the young group, which is expected to be solved with the further increases of OCT scanning depth; (3) This study is a cross-sectional study based on clinical data. The hypothesis proposed in this paper depends on the further confirmation from large, multicenter, and prospective studies; (4) In this study, the age cut-off value was set at 50 years old, which was determined according to the age of previous CSC and the reference age of AMD. Due to the limited number of cases, we did not further study the changes of clinical characteristics of cCSC with age in a smaller age scale, which will be the direction of our further studies.
Conclusions
In conclusion, we have described in detail the unique clinical features of elderly cCSC from the aspects of retina, choroid anatomy, and blood perfusion, and we realize that elderly cCSC patients may have different disease outcomes than young cCSC patients. Elderly cCSC patients have less gender tendency, poorer vision, more serious choroidal and retinal structural damage and ischemia, and have a higher risk of choroidal neovascularization.
Data Availability
The datasets during collected and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Hu J, Qu J, Piao Z, et al. Optical coherence tomography angiography compared with indocyanine green angiography in central serous chorioretinopathy. Sci Rep-UK. 2019;9(1):6149.
Wu M, Fan W, Chen Q, et al. Three-dimensional continuous max flow optimization-based serous retinal detachment segmentation in SD-OCT for central serous chorioretinopathy. Biomed Opt Express. 2017;8(9):4257–74.
Kyo A, Yamamoto M, Hirayama K, et al. Factors affecting resolution of subretinal fluid after selective retina therapy for central serous chorioretinopathy. Sci Rep-UK. 2021;11(1):8973.
Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol. 1996;121(1):26–34.
Podkowinski D, Foessl B, de Sisternes L, et al. Early alterations in retinal microvasculature on swept-source optical coherence tomography angiography in acute central serous chorioretinopathy. Sci Rep-UK. 2021;11(1):3129.
Kishi S, Matsumoto H, Sonoda S, Hiroe T, Sakamoto T, Akiyama H. Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy. PLoS ONE. 2018;13(11): e206646.
Pollithy S, Hoh A, Dobner B, Auffarth GU, Dithmar S. Are there diurnal variations in choroidal thickness? Ophthalmologe. 2015;112(8):665–9.
Hosoda Y, Yoshikawa M, Miyake M, et al. CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy. Proc Natl Acad Sci USA. 2018;115(24):6261–6.
Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina-J Ret Vit Dis. 2009;29(10):1469–73.
Mao J, Lin J, Zhu L, et al. Quantitative assessment of retinal capillary vessel density and foveal avascular zone area in central serous chorioretinopathy using OCTA. Ophthalmologica. 2020;243(5):370–8.
Spaide RF, Campeas L, Haas A, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology. 1996;103(12):2070–9 (2079-2080).
Komatsu H, Young-Devall J, Peyman GA, Yoneya S. Choriocapillary blood propagation in normal volunteers and in patients with central serous chorioretinopathy. Brit J Ophthalmol. 2010;94(3):289–91.
Kitaya N, Nagaoka T, Hikichi T, et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Brit J Ophthalmol. 2003;87(6):709–12.
Gardiner P, Schrode K, Quinlan D, et al. Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites. J Clin Pharmacol. 1989;29(4):342–7.
Fung AT, Yannuzzi LA, Freund KB. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina-J Ret Vit Dis. 2012;32(9):1829–37.
**a Y, Feng N, Hua R. “Choroidal caverns” spectrum lesions. Eye. 2021;35(5):1508–12.
Sakurada Y, Leong B, Parikh R, Fragiotta S, Freund KB. Association between choroidal caverns and choroidal vascular hyperpermeability in eyes with pachychoroid diseases. Retina-J Ret Vit Dis. 2018;38(10):1977–83.
Ciloglu E, Unal F, Dogan NC. The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels. Graef Arch Clin Exp. 2018;256(6):1111–6.
Gackle HC, Lang GE, Freissler KA, Lang GK. Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects. Ophthalmologe. 1998;95(8):529–33.
Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002. Ophthalmology. 2008;115(1):169–73.
Tanaka C, Iwahashi C, Komuku Y, Hozumi K, Mitarai K, Gomi F. Clinical characteristics of central serous chorioretinopathy in patients by age. JPN J Ophthalmol. 2021;65(6):761–8.
Singh SR, Iovino C, Zur D, et al. Central serous chorioretinopathy imaging biomarkers. Brit J Ophthalmol. 2022;106(4):553–8.
Brinks J, van Dijk E, Meijer OC, Schlingemann RO, Boon C. Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities. ACTA Ophthalmol. 2022;100(8):946–59.
Theocharis IP, Lima LH. Vitreoretinal interface in central serous choroidopathy: a retrospective case-control study. ACTA Ophthalmol. 2012;90(7):e505–11.
Nair U, Ganekal S, Soman M, Nair K. Correlation of spectral domain optical coherence tomography findings in acute central serous chorioretinopathy with visual acuity. CLIN Ophthalmol. 2012;6:1949–54.
Matsumoto H, Sato T, Kishi S. Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. AM J Ophthalmol. 2009;148(1):105–10.
Deng K, Gui Y, Cai Y, et al. Changes in the foveal outer nuclear layer of central serous chorioretinopathy patients over the disease course and their response to photodynamic therapy. Front Med-Lausanne. 2021;8: 824239.
Asano KS, Asaoka R, Asano S, Azuma K, Inoue T, Obata R. Elongated photoreceptor outer segment length and prognosis of chronic central serous chorioretinopathy. Retina-J Ret Vit Dis. 2020;40(4):750–7.
Hasegawa T, Okamoto M, Masuda N, Ueda T, Ogata N. Relationship between foveal microstructures and visual outcomes in eyes with resolved central serous chorioretinopathy. Graef Arch Clin Exp. 2015;253(3):343–50.
Yang L, Jonas JB, Wei W. Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2013;54(7):4659–65.
Shin YU, Lee BR. Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy. Am J Ophthalmol. 2012;154(1):155–63.
Liang Z, Qu J, Huang L, et al. Comparison of the outcomes of photodynamic therapy for central serous chorioretinopathy with or without subfoveal fibrin. Eye. 2021;35(2):418–24.
Zhang X, Sivaprasad S. Drusen and pachydrusen: the definition, pathogenesis, and clinical significance. Eye. 2021;35(1):121–33.
Kim JH, Chang YS, Kim JW, Lee TG, Kim CG. Prevalence of subtypes of reticular pseudodrusen in newly diagnosed exudative age-related macular degeneration and polypoidal choroidal vasculopathy in Korean patients. Retina-J Ret Vit Dis. 2015;35(12):2604–12.
Spaide RF. Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness. Retina-J Ret Vit Dis. 2018;38(4):708–16.
Matsumoto H, Mukai R, Morimoto M, Tokui S, Kishi S, Akiyama H. Clinical characteristics of pachydrusen in central serous chorioretinopathy. Graef Arch Clin Exp. 2019;257(6):1127–32.
Kim YH, Chung YR, Kim C, Lee K, Lee WK. The association of pachydrusen characteristics with choroidal thickness and patient’s age in polypoidal choroidal vasculopathy versus central serous chorioretinopathy. Int J Mol Sci. 2022;23(15):8353.
Sheth J, Anantharaman G, Kumar N, et al. Pachydrusen: the epidemiology of pachydrusen and its relevance to progression of pachychoroid disease spectrum. Eye. 2020;34(9):1501–3.
Teo K, Cheong KX, Ong R, et al. Macular neovascularization in eyes with pachydrusen. Sci Rep-UK. 2021;11(1):7495.
Lee SE, Lim HB, Shin YI, Ryu CK, Lee WH, Kim JY. Characteristics of the inner retinal layer in the fellow eyes of patients with unilateral exudative age-related macular degeneration. PLoS One. 2020;15(9): e239555.
Lee J, Byeon SH. Prevalence and clinical characteristics of pachydrusen in polypoidal choroidal vasculopathy: multimodal Image Study. Retina-J Ret Vit Dis. 2019;39(4):670–8.
Friedman E, Smith TR. Clinical and pathological study of choroidal lipid globules. Arch Ophthalmol. 1966;75(3):334–6.
Dolz-Marco R, Glover JP, Gal-Or O, et al. Choroidal and sub-retinal pigment epithelium caverns: multimodal imaging and correspondence with Friedman lipid globules. Ophthalmology. 2018;125(8):1287–301.
Linsenmeier RA, Zhang HF. Retinal oxygen: from animals to humans. Prog Retin Eye Res. 2017;58:115–51.
Scharf J, Freund KB, Sadda S, Sarraf D. Paracentral acute middle maculopathy and the organization of the retinal capillary plexuses. Prog Retin Eye Res. 2021;81: 100884.
Borrelli E, Battista M, Sacconi R, et al. OCT risk factors for 3-year development of macular complications in eyes with “resolved” chronic central serous chorioretinopathy. Am J Ophthalmol. 2021;223:129–39.
Acknowledgements
We thank the participants of the study.
Authorship
All named authors meet the International Committee of Medical Journal. Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
Funding
This study was supported by National Natural Science Foundation of China [81970792, 82171040], Medical Science and Technology Project of Health Commission of Henan Province [YXKC2020026], Technology research projects of Henan Department of Science and Technology [232102310058] and Key Scientific Research Projects of Henan Province Colleges and Universities[23A320067]. The sponsor or funding organization had no role in the design or conduct of this research. The journal’s Rapid Service Fee was funded by the authors.
Author information
Authors and Affiliations
Contributions
Pei Liu and Xuemin ** designed the study. Guangqi An and Chenyu Lu performed the photodynamic therapy. Shu Li, Pei Liu, Bo **, and Guangqi An collected the data. Fan Yang, Haixin Fang, and Chenyu Lu analyzed and interpreted the data. Pei Liu was a major contributor in writing the manuscript. Pei Liu and Guangqi An participated in drafting the manuscript. Xuemin ** and Li** Du revised the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Ethical Approval
This study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University [2022-KY-0547-002], and the procedure was in accordance with the principles of the Declaration of Helsinki. Patients were informed of the risks of invasive examinations and signed informed consent forms.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Liu, P., Fang, H., An, G. et al. Chronic Central Serous Chorioretinopathy in Elderly Subjects: Structure and Blood Flow Characteristics of Retina and Choroid. Ophthalmol Ther 13, 321–335 (2024). https://doi.org/10.1007/s40123-023-00849-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40123-023-00849-z